Keyphrases
Cell Migration
100%
Epithelial-to-mesenchymal Transition
100%
Head-and-neck Cancer
100%
Cancer Cell Lines
100%
Tyrosine Kinase Inhibitor
100%
Epidermal Growth Factor
83%
Transforming Growth Factor-β
83%
Phosphorylation
66%
Erlotinib
66%
Gefitinib
66%
Protein Expression
33%
Phenotypic Change
33%
Protrusion
16%
Cell Protrusion
16%
Growth Factors
16%
Morphological Changes
16%
Signaling Molecules
16%
Western Blotting
16%
Phosphorylation Sites
16%
Tyrosine
16%
Downstream Signaling
16%
Protein Localization
16%
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
16%
Immunofluorescence
16%
Therapeutic Value
16%
Serum-free
16%
Cancer Patients
16%
Study Support
16%
Epidermal Growth Factor Receptor
16%
Potential Therapeutics
16%
Patient Cells
16%
Free Control
16%
Akt Phosphorylation
16%
Mesenchymal Cells
16%
Scratch Test
16%
Phosphorylated Akt
16%
Phosphorylated Epidermal Growth Factor Receptor
16%
Medicine and Dentistry
Cell Migration
100%
Mesenchymal-Epithelial Transition
100%
Tyrosine-Kinase Inhibitor
100%
Head and Neck Cancer Cell Line
100%
Epidermal Growth Factor
83%
Cancer Growth Factor
83%
Gefitinib
66%
Erlotinib
66%
Mitogen-Activated Protein Kinase
50%
Protein Expression
33%
Epidermal Growth Factor Receptor
33%
Head and Neck Cancer
33%
Polyacrylamide Gel Electrophoresis
16%
Morphology
16%
Growth Factor
16%
Cell Line
16%
Signaling Protein
16%
Immunofluorescence
16%
Protein Localization
16%
Western Blotting
16%
Biochemistry, Genetics and Molecular Biology
Cell Migration
100%
Cancer Cell
100%
Mesenchymal-Epithelial Transition
100%
Tyrosine Kinase Inhibitor
100%
Epidermal Growth Factor
83%
Cancer Growth Factor
83%
Gefitinib
66%
Erlotinib
66%
Mitogen-Activated Protein Kinase
50%
Protein Expression
33%
Epidermal Growth Factor Receptor
33%
Morphology
16%
Growth Factor
16%
Tyrosine
16%
Immunofluorescence
16%
Signaling Protein
16%
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
16%
Wound Healing Assay
16%
Western Blotting
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor
100%
Head and Neck Cancer
100%
Cancer Growth Factor
100%
Protein Tyrosine Kinase Inhibitor
100%
Erlotinib
80%
Gefitinib
80%
Epidermal Growth Factor Receptor
40%
Polyacrylamide Gel Electrophoresis
20%
Growth Factor
20%
Western Blot
20%